首页 > 市场调查报告书 > 医疗设备

整形外科

市场调查报告书

商品编码

1547703

全球黏稠补充剂市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Viscosupplementation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球黏稠补充剂市场需求预计将从 2023 年的 53.2 亿美元达到近 125.5 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 10.01%。

黏性补充是骨关节炎的一种治疗方法。这里将一种称为透明质酸的凝胶状液体注入膝关节，起到润滑剂的作用。这种注射有利于膝关节的平滑运动，并减少膝盖周围的肿胀或疼痛。透明质酸可作为关节负荷的减震器并改善膝盖功能。补充黏液不会逆转关节炎的过程或使软骨重新生长，如果关节炎处于早期阶段，则非常有效。这种治疗方法适用于试图延迟关节手术的患者。它也可用于治疗某些类风湿性关节炎。

市场动态

对于骨关节炎患者长期缓解疼痛和恢復活动能力的非手术治疗的日益偏好将是有利于该市场增长的少数基本因素。生活方式引起的疾病的出现以及所有收入群体对适当治疗和治癒的需求显着增加将进一步推动市场成长。对医疗保健行业的高投资使人们能够轻鬆获得可用的诊断和治疗方案，这将促进市场成长。专业骨科诊所和门诊手术中心数量的增加将成为市场的助推器。缺乏黏稠补充剂有效性和安全性的临床证据继续阻碍该市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球黏稠补充剂市场的每个细分市场进行了包容性评估。黏稠补充剂产业的成长和趋势为本研究提供了整体方法。

市场区隔

黏稠补充剂市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

单次注射
三注射
五注射

按最终用途

医院
骨科诊所/ASC

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲粘胶补充剂市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。黏稠补充剂市场的主要参与者包括DePuy Synthes、Fidia Farmaceutici SPA、赛诺菲、Smith & Nephew PLC、Anika Therapeutics Inc.、Seikagaku Corp.、Zimmer Biomet、Ferring Pharmaceuticals BV、Lifecore Biomedical、LG Life Sciences Ltd. 、F.Hoffmann -拉罗氏有限公司。发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：黏稠补充剂公司的竞争格局

黏稠补充剂市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
DePuy Synthes

公司概况
公司收入
产品
最新动态

Fidia Farmaceutici SPA

公司概况
公司收入
产品
最新动态

Sanofi

公司概况
公司收入
产品
最新动态

Smith & Nephew PLC

公司概况
公司收入
产品
最新动态

Anika Therapeutics Inc.

公司概况
公司收入
产品
最新动态

Seikagaku Corp.

公司概况
公司收入
产品
最新动态

Zimmer Biomet

公司概况
公司收入
产品
最新动态

Ferring Pharmaceuticals BV

公司概况
公司收入
产品
最新动态

Lifecore Biomedical

公司概况
公司收入
产品
最新动态

LG Life Sciences Ltd.

公司概况
公司收入
产品
最新动态

F.Hoffmann-La Roche Ltd

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11213813

The global demand for Viscosupplementation Market is presumed to reach the market size of nearly USD 12.55 Billion by 2032 from USD 5.32 Billion in 2023 with a CAGR of 10.01% under the study period 2024-2032.

Viscosupplementation is a treatment procedure for osteoarthritis. Here a gel-like fluid called hyaluronic acid injected into the knee joint acts as a lubricant. This injection facilitates smooth movement of knee joints and reduces swelling or pain around the knee. Hyaluronic acid acts as a shock absorber for loads at the joint and improves knee function. Viscosupplementation does not reverse the arthritic process or re-grow cartilages and is highly effective if the arthritis is in its early stages. This treatment is considered for patients trying to delay getting surgery on the joint. It can be used to treat some instances of rheumatoid arthritis as well.

MARKET DYNAMICS

The increased preference for nonsurgical procedures for long-lasting pain relief and mobility restoration in osteoarthritis patients will be the few essential elements favoring this market's growth. The emergence of lifestyle-induced disorders and a significant rise in the demand for proper treatment and cure among people of all income groups will further propel market growth. High investments in the healthcare industry to enable easy access to available diagnosis and treatment options will boost the market growth. A rise in the number of specialized orthopedic clinics and ambulatory surgical centers will be a market booster. The lack of clinical evidence on viscosupplementation's effectiveness and safety continues to hamper this market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Viscosupplementation. The growth and trends of Viscosupplementation industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Viscosupplementation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Single Injection
Three Injection
Five Injection

By End-use

Hospitals
Orthopedic Clinics/ASCs

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Viscosupplementation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Viscosupplementation market include DePuy Synthes, Fidia Farmaceutici S.P.A, Sanofi, Smith & Nephew PLC, Anika Therapeutics Inc., Seikagaku Corp., Zimmer Biomet, Ferring Pharmaceuticals B.V., Lifecore Biomedical, LG Life Sciences Ltd., F.Hoffmann-La Roche Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. VISCOSUPPLEMENTATION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By End-use
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL VISCOSUPPLEMENTATION MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Single Injection Historic and Forecast Sales By Regions
5.5. Three Injection Historic and Forecast Sales By Regions
5.6. Five Injection Historic and Forecast Sales By Regions

6. GLOBAL VISCOSUPPLEMENTATION MARKET ANALYSIS BY END-USE

6.1. Overview By End-use
6.2. Historical and Forecast Data
6.3. Analysis By End-use
6.4. Hospitals Historic and Forecast Sales By Regions
6.5. Orthopedic Clinics/ASCs Historic and Forecast Sales By Regions

7. GLOBAL VISCOSUPPLEMENTATION MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE VISCOSUPPLEMENTATION COMPANIES

8.1. Viscosupplementation Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF VISCOSUPPLEMENTATION INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. DePuy Synthes
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Fidia Farmaceutici S.P.A
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Sanofi
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Smith & Nephew PLC
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Anika Therapeutics Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Seikagaku Corp.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Zimmer Biomet
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Ferring Pharmaceuticals B.V.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Lifecore Biomedical
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. LG Life Sciences Ltd.
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. F.Hoffmann-La Roche Ltd
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments